Greg Williams

Greg Williams Email and Phone Number

C-Level Biotech & Pharmaceutical Executive | CEO & Board Member | Business Builder @
Greg Williams's Location
Mendham, New Jersey, United States, United States
Greg Williams's Contact Details
About Greg Williams

Proven executive with experience from discovery through commercialization, across small biotech startups to big pharma companies. With a mission-driven leadership style, Greg has led business, medical, scientific, and regulatory teams to build value and realize aggressive goals. Driven by a commitment to improve patient care, he champions innovation in new product development and commercialization to address unmet patient and health system needs as paths to value creation.

Greg Williams's Current Company Details
Population Health Partners / Validae Health

Population Health Partners / Validae Health

C-Level Biotech & Pharmaceutical Executive | CEO & Board Member | Business Builder
Greg Williams Work Experience Details
  • Population Health Partners / Validae Health
    Advisor
    Population Health Partners / Validae Health 2022 - Present
    • Population Health Partners is an investment firm bridging venture capital and private equity, committed to building great companies and generating superior returns for our investing partners by solving the health and economic challenges presented by prevalent diseases.• Validae Health is an organization within Population Health Partners. Its goal is to deliver valid evidence efficiently and it is central to PHP's ability to unlock outsized value from PHP investments.
  • Eloxx Pharmaceuticals
    Ceo & Bod Member | Successfully Transitioned Phase 2 Clinical Stage Company
    Eloxx Pharmaceuticals 2020 - 2021
    Watertown, Massachusetts, Us
    • Set strategic direction and maximized enterprise value by driving clinical and preclinical rare disease programs in cystic fibrosis, Usher syndrome, ADPKD and other rare kidney diseases. • Led the business through the COVID pandemic by developing and implementing multiple global risk mitigation strategies and achieving positive Phase 2 study results.
  • Eloxx Pharmaceuticals
    Coo | Revamped Phase I Strategy To Enable Study Completion & Initiation Of Phase Ii Studies
    Eloxx Pharmaceuticals 2018 - 2020
    Watertown, Massachusetts, Us
    • As a key member of the C-suite team, raised $50M in capital and provided strategic operational leadership for preclinical, clinical, CMC and business activities.• Regularly interfaced with the Board of Directors, led teams through global health authority interactions and preclinical evaluation of extensive compound library to expand corporate portfolio.
  • Radius Health, Inc.
    Chief Development & Operations Officer (2017-2018) | Chief Development Officer (2014-2017)
    Radius Health, Inc. 2014 - 2018
    Boston, Ma, Us
    • As the company’s 6th member, helped build the company from clinical stage to a full integrated commercial organization with 600 employees. • Key member of management team achieving 2014’s highest returning IPO in any business segment and raising $1.05BN in capital. • Expanded company footprint to include a New Jersey site and led teams to submit the company’s 1st NDA achieving a 1st-cycle approval for TYMLOS®.
  • The Medicines Company
    Vp, Neuro & Critical Care Pathway | Innovation Leader | Bu Co-Leader | 116%+ Of Relaunch Target
    The Medicines Company 2010 - 2013
    East Hanover, Nj, Us
    • Co-led the development and implementation of global commercial strategies to launch and relaunch Cleviprex®.• Co-inventor of a novel formulation with new IP securing 20 years of exclusivity and global health authority approvals.
  • The Medicines Company
    Vp, Global Product & Clinical Development | Demonstrated Economic Value Proposition
    The Medicines Company 2008 - 2010
    East Hanover, Nj, Us
    • Led team developing health economic models demonstrating cost savings due to improved blood pressure control leading to expanded commercial acceptance.• Co-designed and implemented new clinical trials to expand labeling and eligible patient populations. • Co-led manufacturing process improvements and global health authority interactions enabling product reintroduction post-recall and additional global approvals.
  • The Medicines Company
    Vp, Regulatory Affairs & Program Management | Obtained 1St-Cycle Fda Approval For Nme Nda
    The Medicines Company 2006 - 2008
    East Hanover, Nj, Us
    • Built and led team with aggressive timelines to submit a high-quality NDA, gaining 1st-cycle FDA approval of novel IV antihypertensive.
  • Nps Pharmaceuticals
    Vp, Regulatory Affairs & Regulatory Compliance | Led Company’S 1St Nda & Maa
    Nps Pharmaceuticals 2005 - 2006
    Bedminster, New Jersey, Us
    • Led cross-functional organization to submit 1st NDA and MAA, leading to approval of Preotact®.• Created company’s first cGXP compliance group and passed all pre-approval audits.
  • Nps Pharmaceuticals
    Vp, Program Management | Accelerated Development & Commercialization Process
    Nps Pharmaceuticals 2004 - 2006
    Bedminster, New Jersey, Us
    • Developed and implemented PM best practices for continuous business process optimization.• Chaired Development Operating Committee governing portfolio review (4 NCEs) and led key alliance steering committee.

Greg Williams Skills

Biotechnology Regulatory Affairs Clinical Trials Clinical Development Fda Pharmaceutical Industry Oncology Strategy Drug Development Biopharmaceuticals Pharmaceutics Life Sciences Commercialization Leadership Neurology Manufacturing Cross Functional Team Leadership Regulatory Submissions Clinical Research Business Strategy Risk Management Quality Assurance Technology Transfer Strategic Planning Business Planning Quality Management Operations Management Crisis Management Product Launch Gmp Sop U.s. Food And Drug Administration Nonclinical Development Formulation Marketing Strategy Urology Lifesciences Innovation

Greg Williams Education Details

  • Cornell Johnson Graduate School Of Management
    Cornell Johnson Graduate School Of Management
    Master Of Business Administration (Mba)
  • Rutgers University
    Rutgers University
    Biopharmaceutics
  • Fairleigh Dickinson University
    Fairleigh Dickinson University
    Chemistry
  • Fairleigh Dickinson University
    Fairleigh Dickinson University
    Chemistry And Biology

Frequently Asked Questions about Greg Williams

What company does Greg Williams work for?

Greg Williams works for Population Health Partners / Validae Health

What is Greg Williams's role at the current company?

Greg Williams's current role is C-Level Biotech & Pharmaceutical Executive | CEO & Board Member | Business Builder.

What is Greg Williams's email address?

Greg Williams's email address is gr****@****rma.com

What is Greg Williams's direct phone number?

Greg Williams's direct phone number is +161755*****

What schools did Greg Williams attend?

Greg Williams attended Cornell Johnson Graduate School Of Management, Rutgers University, Fairleigh Dickinson University, Fairleigh Dickinson University.

What are some of Greg Williams's interests?

Greg Williams has interest in Teamwork, Health Economics And Chemistry, Scientific Achievement, Pharmacokinetics, Nonclinical.

What skills is Greg Williams known for?

Greg Williams has skills like Biotechnology, Regulatory Affairs, Clinical Trials, Clinical Development, Fda, Pharmaceutical Industry, Oncology, Strategy, Drug Development, Biopharmaceuticals, Pharmaceutics, Life Sciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.